Families | HPV Vaccine | Liquid Biopsy, Cancer Information Highlights, October 21, 2020

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Video—Support for Your Family When a Child Has Cancer   Everyone in the family needs support when a child has cancer. Get tips from oncology experts and parents about self-care, marriage, and support for siblings. Large Study Confirms That HPV Vaccine Prevents Cervical Cancer   Widespread use of the human papillomavirus (HPV) vaccine reduces the number of women who will develop cervical cancer. Among girls vaccinated before age 17, the vaccine reduced cervical cancer cases by 90%. Blood Tests That Can Help Guide Cancer Treatment The Food and Drug Administration recently approved two new blood tests, known as liquid biopsies, that can inform treatment decisions for people with cancer. This story explores how the tests are used and which types of cancer the tests can detect. A More Treatable Kind of Metastatic Cancer? People with oligometastatic cancer have only a few metastatic tumors. Researchers are studying whether treating these tumors directly with surgery or stereotactic body radiation therapy can help people live longer and improve their quality of life. Study Reinforces Treatment Idea   A study led by NCI researchers supports a recent idea that targeting an enzyme called WRN may be a new way to treat certain cancers with a genetic feature called microsatellite instability-high. No existing drugs are known to target the enzyme, but researchers are looking for one. Melanoma Cells Are More Likely to Spread after Stopover in Lymph Nodes Melanoma cells that pass through the lymphatic system before entering the bloodstream spread more readily than cells that enter the bloodstream directly. The finding could lead to new treatment approaches. NCI Is Driving Discovery in Cancer Research This section of the NCI Annual Plan & Budget Proposal for Fiscal Year 2022 summarizes how NCI supports progress against cancer across the cancer continuum. Learn more about how NCI invests in research, supports the research workforce, and helps maintain research infrastructure. PDQ Updates Thymoma and Thymic Carcinoma Treatment We've revised our PDQ summary on thymoma and thymic carcinoma to include sunitinib as a targeted therapy option that may be used to treat recurrent thymoma or recurrent thymic carcinoma.   Also of Interest Advances in Breast Cancer Research This page highlights some of the latest research in breast cancer, including advances that may soon translate into improved care, NCI-supported programs that are fueling progress, and research findings from recent studies. Contact Us for Help Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892